Measurement of Chitinase Activity in Biological Samples
August 22nd, 2019
Presented here is a simple method to measure chitinase activity in biological fluids such as bronchoalveolar lavage or serum.
This method allows a more effective way to quantify chitinase activity in biological samples. Chitinase activity has been shown to serve as a good marker for diagnosis and therapeutic efficacy in numerous conditions and diseases. Earlier methods for the measurement of chitinase activity were often time consuming and difficult to perform, both problems that have been solved by the assay shown here.
This technique will help fulfill the potential chitinases have as a diagnostic and therapeutic marker by making it easier to measure chitinase activity;for example, it can be used to monitor the treatment of Gaucher disease because chitinase activity has been shown to decrease during effective treatment. Begin by preparing substrates, standards, and solutions for the assay. Prepare 1x McIlvain buffer according to the manuscript directions and use it to dilute chitin substrates to 500 micromolar each.
Dissolve 4-methylumbelliferone, the standard, to a concentration of 0.1 millimolar in stop buffer to create a standard curve stock solution. For every 10 samples, mix 2.17 milliliters of 1x McIlvain buffer with 100 microliters of the chitin substrate to create a working solution, then pipette 95 microliters of the working solution into each well of a 96-well plate. Add five microliters of the test sample to each well and mix it into the working solution.
Cover the plate and shake it for five seconds, then incubate the plate at 37 degrees Celsius for 15 minutes to allow the enzymatic reaction to take place. Meanwhile, dilute the stock solution of 4-methylumbelliferone to make a five-micromolar working standard solution and create a standard curve by preparing a series of dilutions according to the manuscript. Start with the five-micromolar concentration and mix each dilution well.
After the incubation, add 200 microliters of stop buffer to each well to stop the reaction. Add 300-microliter duplicates of each standard to the same plate, then read the plate at an excitation of 360 nanometers and an emission of 455 nanometers. This protocol was successfully used to measure chitinase activity in bronchoalveolar lavage and serum fluid of wild type and chitotriosidase over-expressing transgenic mice.
The assay confirms that overexpression of the CHIT-1 gene in mice results in increased chitinase activity. A standard curve was used to determine chitinase based on fluorescence of the samples. The most important thing to remember when first attempting the protocol is to add the samples as quickly and efficiently as possible while still mixing thoroughly.
When you first start out, it may be beneficial to do fewer samples per run to ensure accuracy in measurements, due to a shorter incubation period.
View the full transcript and gain access to thousands of scientific videos
Overview
This article presents a method for measuring chitinase activity in biological fluids, such as bronchoalveolar lavage or serum. This technique simplifies the quantification of chitinase, a marker for various diseases.
Key Study Components
Area of Science
- Biochemistry
- Clinical diagnostics
- Therapeutic monitoring
Background
- Chitinase activity is a potential marker for diagnosis and treatment efficacy.
- Previous measurement methods were time-consuming and complex.
- Effective monitoring of conditions like Gaucher disease is crucial.
- Chitinase levels can indicate treatment success.
Purpose of Study
- To provide a simpler method for measuring chitinase activity.
- To enhance the utility of chitinases as diagnostic markers.
- To facilitate monitoring of therapeutic responses in patients.
Methods Used
- Preparation of substrates, standards, and solutions for the assay.
- Dilution of chitin substrates to 500 micromolar using 1x McIlvain buffer.
- Application of the assay to biological samples.
- Quantification of chitinase activity in fluids.
Main Results
- The method provides a more effective way to quantify chitinase activity.
- Chitinase activity can be reliably measured in biological samples.
- The assay can monitor treatment efficacy in conditions like Gaucher disease.
- Results indicate a decrease in chitinase activity with effective treatment.
Conclusions
- This method simplifies the measurement of chitinase activity.
- It enhances the potential of chitinases as diagnostic and therapeutic markers.
- Future applications may improve patient monitoring and treatment outcomes.
Frequently Asked Questions
Executive Industry Relevance
Chitinase activity serves as a biomarker for disease severity and therapeutic response in type 2 inflammatory conditions and lysosomal storage disorders. This simplified assay enables reliable quantification in biological fluids, supporting target validation and mechanistic de-risking in discovery programs. The method improves assay readiness for preclinical and translational workflows by providing a reproducible, quantitative readout.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of chitinase's role in host immunity and allergic disease pathways.
- Operational Value: Provides a rapid, standardized method to assess target engagement in disease models.
Screening & Assay Development
- Scientific Value: Generates quantitative fluorescence data linked to enzymatic activity for hit confirmation.
- Operational Value: Uses a 96-well plate format compatible with high-throughput screening platforms.
- Scientific Value: Supports biomarker qualification by correlating activity with disease states in murine models.
Translational & Preclinical Research
- Scientific Value: Measures chitinase as a translational biomarker in BAL and serum across species.
- Operational Value: Enables longitudinal monitoring of therapeutic efficacy in preclinical studies.
- Scientific Value: Facilitates go/no-go decisions by linking target modulation to phenotypic outcomes.
Pipeline & Workflow Integration
The assay fits within the discovery continuum from target validation to preclinical efficacy testing, offering a measurable link between target modulation and disease-relevant phenotypes.
- Discovery Biology: Supports hypothesis testing on chitinase function in inflammatory and metabolic disease models.
- Screening: Delivers reproducible, quantitative outputs for assay standardization across laboratories.
- Analytics: Uses fluorescence readouts at 360 nm excitation and 455 nm emission for precise activity quantification.
- Translational Research: Connects enzymatic activity changes to therapeutic response in Gaucher disease models.
- Enterprise Reuse: Adaptable to human samples and multiple model organisms due to enzyme conservation.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target-disease relationships through biomarker alignment.
- Operational Value: Reduces assay variability with a simple, quick protocol requiring minimal hands-on time.
- Strategic Value: Improves capital efficiency by enabling early biomarker-driven compound prioritization.
- Portfolio Impact: Supports risk-adjusted advancement by providing mechanistic readouts on target modulation.
Implementation Considerations
- Requires expertise in enzymatic assay design and fluorescence detection.
- Depends on access to a microplate reader with 360 nm excitation and 455 nm emission filters.
- Necessitates standardization of substrate preparation and incubation timing across users.
- Adaptation to human serum may require optimization for matrix effects and endogenous interferents.
- Limited to relative activity measurements unless absolute quantification is established via purified enzyme standards.
